10月16日，Iovance Biotherapeutics盘中下跌5.54%，报13.9美元/股，成交额1651.33万美元。
Iovance Biotherapeutics所在的生物科技行业中，Moderna, Inc.跌6.49%，艾伯维公司涨0.14%，安进涨0.43%，吉利德科学跌0.62%，福泰制药跌0.12%。
公司专注于自体肿瘤浸润淋巴细胞（TIL）疗法的开发与商业化，核心方向包括转移性黑色素瘤等实体瘤治疗。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.